Syndax Pharmaceuticals, Inc. (SNDX) Balance Sheet
As of 2026-06-30 (10-Q), Syndax Pharmaceuticals, Inc. (SNDX) reported total assets of $703.7M, total liabilities of $688.6M and shareholders' equity of $15.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $336.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SNDXSyndax Pharmaceuticals, Inc.Follow SNDX — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 23.8 | 35.2 | 33.8 | 24.6 | 115.2 | 222.0 | 74.4 | 295.4 | 154.1 | 134.9 | 336.5 | |
| Short-term investments | 81.5 | 94.8 | 47.1 | 35.2 | 177.8 | 218.0 | 401.4 | 275.3 | 418.8 | 259.1 | 211.4 | |
| Receivables | — | — | — | — | — | — | — | 0.0 | 7.6 | 38.0 | 45.1 | |
| Inventory | — | — | — | — | — | — | — | 0.0 | 0.4 | 32.8 | 33.2 | |
| Current assets | 108.5 | 133.4 | 83.3 | 62.3 | 298.9 | 448.4 | 489.8 | 580.9 | 603.1 | 528.1 | 675.0 | |
| Total assets | 109.0 | 137.2 | 83.9 | 63.5 | 300.6 | 449.7 | 497.2 | 612.9 | 724.8 | 529.7 | 703.7 | |
| Current liabilities | 10.4 | 15.8 | 16.1 | 18.4 | 18.9 | 20.7 | 29.1 | 58.1 | 103.5 | 120.1 | 99.7 | |
| Long-term debt | — | — | — | — | — | — | — | 0.0 | 331.6 | — | — | |
| Short-term debt | — | — | — | — | — | — | — | 0.0 | 337.9 | 350.0 | 350.0 | |
| Total liabilities | 24.9 | 32.9 | 30.9 | 31.9 | 48.4 | 41.3 | 29.8 | 58.7 | 436.7 | 465.1 | 688.6 | |
| Shareholders' equity | 84.1 | 104.3 | 53.0 | 31.6 | 252.2 | 408.4 | 467.4 | 554.2 | 288.1 | 64.6 | 15.1 |
USD millions · SEC XBRL
Syndax Pharmaceuticals, Inc. — questions
- How much cash does Syndax Pharmaceuticals, Inc. have?
- $336.5M in cash and cash equivalents as of 2026-06-30.
- How much debt does Syndax Pharmaceuticals, Inc. have?
- $350.0M due within a year as of 2026-06-30.
- What are Syndax Pharmaceuticals, Inc.'s total assets?
- $703.7M as of 2026-06-30.
- What is Syndax Pharmaceuticals, Inc.'s shareholders' equity?
- $15.1M as of 2026-06-30.
Every figure on this page comes from Syndax Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.